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ABSTRACT
Acne is a prevalent skin disorder and is displayed through various different
incidences. Cystic acne, a severe form of acne that is difficult to treat, reaches
deep into the skin underneath the epidermis layer and produces painful, inflamed
cysts that contain sebum, dead skin cells, and Propionobacterium acnes, the
acne causing bacteria. Because this is an uncomfortable type of acne and is
tough to treat, researchers have developed and tested a number of treatments to
determine the best course of treatment for reducing and potentially eradicating
cystic acne. These treatments are most commonly in the form of systemic or
topical treatments, but other types of treatments are still considered as a possible
course of action. According to this research, the most effective treatment that is
currently available is isotretinoin, commonly known by the brand name Accutane.
A short survey of medical professionals was conducted in order to determine
what they most frequently prescribe when treating cystic acne and what the
benefits and consequences of those treatments are. Their answers were
compared to current research and determined that systemic Accutane is the
most successful course of treatment for most patients with cystic acne due to the
medications ability to reduce and potentially eradicate all cystic acne lesions.
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INTRODUCTION
Acne is a chronic skin condition that affects many people every year. This
skin disorder has a high incidence and prevalence amongst all age groups.
Cystic acne is a severe form of acne that causes unpleasant cysts on the
face, chest, neck, back, or behind regions of the body and can lead to
disfigurement. Determining a treatment for this form of acne may be an
extensive and difficult process depending on the patient’s response to initial
treatments. Because of this, researchers have discovered and developed
many forms of treatments for cystic acne from systemic therapy to light
therapy. The goal of this thesis is to discuss the basis of cystic acne and to
evaluate the diverse treatments that are currently available.

5
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THE ANATOMY OF THE SKIN
In order to understand the genesis of acne, one must first understand

the anatomy of the skin and the components that allow acne to form. The
anatomy of the skin is broken down into three main layers: the epidermis,
dermis, and subcutaneous tissue. These layers are listed from most
superficial to the deepest layer. (See figure one).
a. The epidermis layer, the outermost skin layer that can be easily observed,
contains the sensory nerve endings as well as the pore openings and hair
shaft (McKinley, O’Loughlin, Bidle, 2015). One of the main functions of the
epidermis layer is to be the first line of protection from ultraviolet light,
infections, and prevent detrimental damage to the integumentary system
(Chu, 2012). This layer does not contain blood vessels or capillaries, but it
does contain four to five layers of keratinized, stratified squamous
epithelium (LeMaster, Matern, Morrison-Graham, etc., 2019). The keratin
proteins within the epidermis skin cells assist in protection as well as cell
migration, cell growth, transportation of resources, and recovery from
injuries to the skin (Genetics Home Reference. 2019).
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b. The dermis layer, which is the middle layer of the skin, is constructed of
two layers of connective tissue (LeMaster, Matern, Morrison-Graham, etc.,
2019). The dermis contains the nerve fibers with sensory nerve endings
branching off of the fibers and stretching into the top of the dermis layer,
which is defined as the papillary layer (McKinley, O’Loughlin, Bidle, 2015).
The bottom layer of the dermis is the reticular layer, which contains the
majority of the appendages within the skin. The nerve fibers and sensory
nerve endings allow the body to feel sensations on the skin whether the
body is lightly touched or injured (American Academy of Dermatology,
2013). The dermis layer also includes capillaries and the erector pili
muscles. The capillaries within this layer provide the nutrients for the
epidermis layer since that layer does not have capillaries or blood vessels
(LeMaster, Matern, Morrison-Graham, etc., 2019). The erector pili muscles
provoke the involuntary process that is observed as the hair on our body
to “standing up” and the skin may exhibit a goose bump like texture when
someone is cold or frightened. The scientific word for the hair rising is
piloerection (Piloerection. (n.d.) Merriam-Webster). The most notable
appendages located within the dermis layer of the skin are the sweat
glands, sebaceous glands, and the hair follicles. The sweat glands are
responsible for releasing sweat through the sweat gland duct to the sweat
pore or hair follicle (McKinley, O’Loughlin, Bidle, 2015, pg. 201). Sweating
assists the body by excreting sweat in order to cool the body down so that
it does not overheat and cause damage (American Academy of
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Dermatology, 2013). The sebaceous glands produce sebum, which is an
oily secretion that is released onto the hair or within the hair follicle
(McKinley, O’Loughlin, Bidle, 2015, pg. 202). This release is motivated by
male and female sex hormones during puberty (McKinley, O’Loughlin,
Bidle, 2015, pg. 202). Sebum assists in keeping the skin from drying out,
creating a waterproof barrier, and may create a level complexion.
However; an overproduction of sebum during puberty and other points in
the human life span where hormones are produced in excess, such as
menopause or pregnancy, may result in acne.

8
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c. The subcutaneous layer, the deepest layer of the skin, consists of
connective tissue such as areolar and adipose connective tissue, which
insulate the body (McKinley, O’Loughlin, Bidle, 2015). The adipose tissue
provides extra padding around the bodies muscles and bones and it also
assists in regulating the body’s internal temperature by controlling whether
or not heat is retained or released from the body (American Academy of
Dermatology, 2013). The connective tissue within this layer is what
connects the integumentary system to the body’s muscles and bones
(American Academy of Dermatology, 2013). The veins and arteries that
travel through the integumentary system are also located within the
subcutaneous layer (McKinley, O’Loughlin, Bidle, 2015). The nerve cells
from the dermis layer extend through the subcutaneous layer and travel
through the body in order to relay information of touch and sensations to
the brain (American Academy of Dermatology, 2013).
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Figure 1: Diagram of the Skin Anatomy:

McKinley, O’Loughlin, Bidle, 2015
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ACNE VULGARIS
Acne vulgaris is the medical term for common acne (The Free Dictionary).

This skin condition is the most prevalent throughout the United States with an
estimated number of forty to fifty million people who are affected (American
Academy of Dermatology, n.d.). Acne affects approximately 85% of teenaged
patients due to their increase in sex hormones during puberty (Ayer, Burrows,
2006). Acne occurs more frequently in teenagers than in middle-aged adults
because of the spike in hormone levels, however; anyone may experience
acne at any age (American Academy of Dermatology, n.d). Both males and
females are affected by acne, however; because women often experience
more hormonal changes than men, women are more frequently affected by
acne (American Academy of Dermatology, n.d). The changes in hormones in
females that could lead to the formation of acne may be attributed to
menstruation, pregnancy, menopause, and occasional hormone imbalances.
Acne is caused by an overproduction of sebum and a build up of
unnecessary substances on the skin the leads to clogged pores and hair
follicles in the dermis layer of the skin (American Academy of Dermatology,
n.d.). These unnecessary substances include certain skincare products,
make-up, dead skin cells, and the acne causing bacteria, Propionobacterium
acnes (American Academy of Dermatology, n.d.). These substances become
trapped in a pore or a hair follicle along with excess sebum and are unable to
escape (American Academy of Dermatology, n.d.). Therefore, this
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combination of substances will form an inflamed pimple or nodule-like acne
spot on the surface of the skin (American Academy of Dermatology, n.d.).
The reason for an overproduction of sebum and the occurrence of P.
acnes varies from patient to patient. Genetics, androgens (such as
testosterone), stress, and excessive sweating are known causes that may
affect the formation of acne (Ayer, Burrows, 2006). Endocrine disorders, such
as polycystic ovarian syndrome, a hormone disorder that affects growth and
sexual hormones, are also capable of causing an acne breakout (Ayer,
Burrows, 2006). Other factors that lead to etiopathogenesis that are not
genetic or a part of a natural body function include smoking cigarettes and the
ingestion of medicines and chemicals such as oral contraceptives, bromides,
corticosteroids, and dioxins (Ayers, Burrows, 2006).
Acne may appear in many different forms and severities depending on the
patient’s hormone levels and sebum production. The blemishes often occur
on the face, chest, neck, shoulders, back, the upper arms, or backside
depending on the amount of friction, sweat, and sebum produced on these
areas of the body (American Academy of Dermatology, n.d.).
Researchers and medical professionals that work to develop and pinpoint
the most effective treatments for acne recommend that this skin condition be
treated as soon as possible in order to prevent acne scars and because it is
better to determine what is the best method of treatment for the patient early
on rather than later (Ayer, Burrows, 2006).
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Treating acne is not a short-term situation. In order for patients to be
equipped to handle their skin condition, it’s best to explore what treatment
method would be the most comfortable for them to continue for a long period
of time while still treating the skin inflammation caused by the acne lesions
(Ayer, Burrows, 2006). The medical professional treating patients with acne
should also inform them of appropriate cosmetic and hair products that will
not aggravate the pre-existing acne or result in the formation of new acne
lesions (Ayer, Burrows, 2006).
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TYPES OF ACNE
Acne is displayed in various forms depending on the causes and potential

hormone levels of an individual. Researchers have currently identified
multiple different types of acne. The simplest known form of acne lesion is a
comedo (WebMD), which is a hair follicle that is clogged with sebum and
dead skin cells, and they are either an open or closed comedone.
(Comedones are the plural form of comedo) (WebMD). An open comedo is
also known as a blackhead and a closed comedo is known as a whitehead
(WebMD).
Blackheads are clogged pores in the skin that have a dark colored
appearance (InformedHealth.org, 2013). The dark color is not due to a build
up of dirt, but is a result of the skin pigment melanin reacting with oxygen in
the air because blackheads are open comedones (InformedHealth.org, 2013).
Blackheads are difficult to extract from the skin because the dead skin cells,
sebum, and acne causing bacteria that make up this open comedo are not on
the surface of the skin. A whitehead is a closed comedo with a small yellow or
whiteish oil-filled bump (InformedHealth.org, 2013). Whiteheads are easier to
extract because the oil-filled bump is easily popped by friction or pressure.
Papules are a step up from whiteheads. Papules are the typical inflamed
pimple that most people associate with acne, and they occur as small bumps
across the affected area (InformedHealth.org, 2013). Another pimple or bump
that is more serious than a papule is a pustule. A pustule is a bump filled with
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yellow pus, and both papules and pustules may be popped to release the
bumps contents (InformedHealth.org, 2013).
A more severe type of acne that is more difficult to treat is nodular acne.
The nodules are inflamed painful, reddish bumps on the skin that may feel
like knots under the skin (Palmer, 2019). Nodules reach deep into the skin
and while they may have a whitehead, they usually cannot be popped and will
stay deep under the epidermis layer until the nodule is treated (Palmer,
2019). Another type of severe acne, which is the focus of this paper, is cystic
acne. Cystic acne is also an inflamed, red, and tender bump that reaches
deep into the skin’s layers, however; it occurs as cysts within the skin instead
of nodules (de Bellefonds, 2018). This type of acne will be discussed in depth
further into the paper.
A form of acne that is less well known amongst the general population is a
severe form of acne known as acne conglobata. This type of acne includes
multiple irritated nodules that form a connection under the skin and branch
towards other nodules on the chest, neck, arms or the bottom regions of
those affected (WebMD). Researchers have determined that this form of acne
may affect men more often because of steroid or testosterone usage, and it
may cause scarring (WebMD).
A more common form of acne is acne mechanica, which occurs due to
friction, pressure, and heat against the skin of the forehead due to frequent
use of sports helmets and baseball caps (WebMD). Because the main source
of this form of acne is related to sports equipment, acne mechanica is
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common amongst athletes, and they have been encouraged to use absorbent
materials under their helmets or caps and to shower shortly after wearing the
equipment (WebMD).
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CATEGORIES OF ACNE
Dermatologists have narrowed down the types of acne to three different

categories based on the amount of whiteheads, blackheads, irritated bumps,
and lesions that occur on a persons skin (See figure two). The first category
of acne is mild acne, which consists of blackheads and/or whiteheads
(InformedHealth.org, 2013). A patient with mild acne will have fewer or
smaller pimples than those with more intense acne, and therefore, mild acne
will be easier to treat and clear up than others (InformedHealth.org, 2013).
The second category of acne is moderate acne, which is normally treated
by a dermatologist with a prescription medication in order to reduce the
amount of lesions over time (WebMD). A patient with moderate acne will have
more noticeable pimples as well as inflamed papules or pustules and this
form of acne will be more difficult to treat (InformedHealth.org, 2013).
The third category of acne is known as severe acne, which consists of
papules, pustules, nodules, and cysts (InformedHealth.org, 2013). This
category of acne often leads to the formation of acne scars because the types
of acne involved are stubborn and difficult to treat (InformedHealth.org, 2013).
In order to cure or reduce this form of acne, it has to be treated by a
dermatologist who in particular situations, may prescribe strong topical or
systemic acne treatments or sometimes inject a corticosteroid into a targeted
nodule or cyst in order to reduce the inflammation (WebMD).
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Figure 2: Categories of Acne
Figure 2a: Mild Acne:

https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary

Figure 2b: Moderate Acne:

https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary
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Figure 2c: Severe Nodulocystic Acne:

https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary
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CAUSES OF CYSTIC ACNE

Although there are many types of acne, this research is geared towards the
formation and treatment of cystic acne. Cystic acne is defined in medical terms
as severe acne with the formation of follicular cysts that are enclosed in a mixture
of keratin and sebum, which may rupture and scar (The Free Dictionary). Acne
cysts are present on the surface of the skin if the inflammation of the skin
continues deep into the affected pore or hair follicle (American Academy of
Dermatology, n.d) This inflammation is caused by the previously mentioned
unnecessary substances, such as dead skin cells and P. acnes, and an
overproduction of sebum (American Academy of Dermatology, n.d.). (See figure
three)
A universal cause for the overproduction of sebum that causes cystic acne
has not been determined yet due to the differences in lifestyles, skin types, and
hormone levels. A key factor that may potentially play a role in the formation of
acne for some patients is their diet. Researchers are still debating on whether or
not an increase in sugar or sugary foods in a patient’s diet and an increase of
insulin in the bloodstream due to the amount of glucose ingested could lead to
acne formation (Huntley, 2003). This increase in insulin could create an increase
in the production of endogenous sex hormones, such as testosterone and
estrogen, and therefore the cells within the sebaceous glands could be
stimulated and begin overproducing sebum, which may result in cystic acne
(Huntley, 2003).
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Researchers do know that a surge in hormones, such as those during
adolescent teenage years, is one of the most prevalent elements that result in
an overproduction of sebum and acne causing bacteria (MacGill, 2017).
However; cystic acne is not restricted to teenagers and may affect all ages
(MacGill, 2017). As previously mentioned when discussing the formation of
general acne, certain hormonal fluctuations that are caused by oral and
hormonal birth control implants, pregnancy, the menstrual cycle, stress, and
other hormone therapies will also increase cystic acne production (MacGill,
2017). High levels of humidity and the usage of lotions, cleansers, and makeup that contain greasy or oily compounds may also result in the formation of
cystic acne lesions (MacGill, 2017). If a person who is prone to cystic acne
lesions is exposed to chemicals and drugs such as lithium, phenytoin,
corticosteroids, and isoniazid he or she may notice an increase in cystic
lesions as a form of reaction to these compounds (MacGill, 2017). However,
for some cystic acne patients, their acne may occur due to a genetic
disposition no matter their environment or exposure to acne triggering
products (MacGill, 2017).
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Figure 3: Diagram of Nodulocystic Acne Below the Skin:

https://www.getproactiv.ca/on/demandware.static/-/Sites-Proactiv-Library/en_CA/content/images/yourskin/nodule.jpg
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DIAGNOSIS & SYMPTOMS OF CYSTIC ACNE
Cystic acne is diagnosed by having the lesions inspected by a medical

professional such as a family medicine doctor, a dermatology physician
assistant, or most likely, a dermatologist. The medical professional will
observe the lesions and determine if they are cystic and also count the other
acne lesions (open and closed comedones, papules, pustules, and nodules)
to determine the degree of severity for treatment purposes (Cole, 2009). The
lesions observed may be on the back, chest, or face of the patient (Cole,
2009). (See figure four).
The superficial symptoms of cystic acne lesions are characteristically
described as red, painful to the touch, elevated bumps on the areas of the
body that are acne prone (face, chest, and back) (Cole, 2009). A cystic lesion
is normally accompanied by smaller lesions around the cyst, and therefore
causes the affected area to be painful or sensitive (Cole, 2009). These
lesions are also more visible than less severe forms of acne, which may lead
to self-esteem issues over one’s appearance as well as a decline in mood
(MacGill, 2017). This puts patients with cystic acne at a higher risk for
psychological problems and emotional distress than those with a less severe
form of acne (MacGill, 2017). Cystic acne may also result in permanent
damage to the skin by producing scars in the form of either small, deep pits
called “icepick scars,” shallow depressions in the skin, larger pits, or red,
raised scars (MacGill, 2017).
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Figure 4: An Example of Cystic Acne:

https://optinghealth.com/wp-content/uploads/2017/07/Cystic-Acne-1-e1503829566899.png
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TREATMENTS FOR CYSTIC ACNE
Cystic acne falls under the category of severe acne, and therefore it may

be difficult to determine a universally effective treatment for patients that
suffer from this type of skin disorder. It may also be difficult to completely
eradicate all lesions or scars produced especially if the treatment is not an
effective match for the patient. Thankfully, there are many different forms of
acne treatments such as systemic (oral antibiotics/medicines), topical
(creams or gels), as well as light, vitamin, or herbal therapy.
a. Systemic
Systemic treatments have earned the title of the most common type
of treatment for cystic acne because they are known to decrease
swelling and reduce the redness that occurs with cystic lesions
(American Academy of Dermatology). Some of the oral antibiotics
known amongst the medical community that may treat cystic acne are
doxycycline, trimethoprim-sulfamethoxazole, and Isotretinoin (Cole,
2017). Female patients may also be prescribed an oral contraceptive,
such as norethindrone, which is a progesterone pill used to balance
female hormone levels (Cole, 2017).
Oral doxycycline is the most prescribed oral tetracycline in the
United States due to this antibiotic being a low risk medication for
causing adverse reactions (Rosso, 2015). Doxycycline is a variation of
the medication tetracycline, which is an antibiotic that may be used as
treatment for various bacterial infections such as acne or sexually

A RISK BENEFIT ANALYSIS OF TREATMENTS FOR CYSTIC ACNE

26

transmitted diseases (Cunha, 2018). Doxycycline is capable of treating
moderate-to-severe acne and is sometimes paired with extendedrelease minocycline tablets in order to increase effectiveness and
reduce side effects such as gastrointestinal issues, photosensitivity,
and dizziness (Rosso, 2015). Doxycycline works by preventing further
bacterial growth, and the medication kills bacteria while reducing the
production of acne causing oils in the pores (MedlinePlus, 2017).
Trimethoprim-sulfamethoxazole is another oral antibiotic used for
treating moderate-to-severe acne, however; it is known to be a higher
risk medication for adverse reactions, so it is only prescribed when
other antibiotics, such as doxycycline, are not effective (Huntley,
2003). Trimethoprim-sulfamethoxazole is also used to treat infections
such as dysentery, urinary tract infections, pneumonia, and severe
cases of chronic bronchitis (McCarty & Rosso, 2011). This medication
has been compared to isotretinoin (to be discussed shortly) because it
presents a similar response, but does not provide a long-term solution
for preventing severe acne once the medication is no longer being
administered (Huntley, 2003). Trimethoprim-sulfamethoxazole works
by deterring the production of folates, which are salts or esters of folic
acid required for bacterial DNA production (McCarty & Rosso, 2011).
Isotretinoin, also known by the brand name Accutane, is defined as
an oral acne treatment that is a derivative of vitamin A that exploits
retinoid receptors, which are related to vitamin A, and there is no age
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restriction on who may be prescribed this systemic treatment
(Hitzeman, 2016). This is currently the most effective treatment for
treating cystic acne because this drug is able to cutback on the amount
of comedone production and sebum production on the surface and the
pores and ducts within the dermis layer (Layton, 2009). This prevents
the acne causing bacteria from reproducing in a hostile environment
(Hitzeman, 2016). Antibiotics (in general) work by decreasing the cell
growth within the sebaceous glands and are able to decrease the
bacteria P. acnes and the inflammation that this bacteria causes
(Hitzeman, 2016). Isotretinoin is not recommended as the first course
of treatment to be prescribed for patients with moderate-to-severe
acne because it is a teratogenic drug that posses a risk to the fetus if a
female who is on the medication were to become pregnant (Hitzeman,
2016). Females on isotretinoin who are within childbearing years are
required to use two forms of birth control if they are sexually active.
They are also required to take two pregnancy tests before this
medication is prescribed. This requirement continues every month
while they are taking isotretinoin and one month after the patient has
completed their prescribed dosage. The patient must also refrain from
donating blood while on this medication to protect pregnant or soon to
be pregnant women from receiving potentially harmful blood
(Hitzeman, 2016).
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Common side effects of isotretinoin include dry lips, eyes, and skin,
including parts of the body other than those affected by acne lesions
(Hitzeman, 2016). The medical professional prescribing this strong
systemic treatment will recommend their patient to take the medication
for a certain number of months based on the severity of their acne.
This will be adjusted based on the patient’s progress and once they
have completed their prescribed dosage. Isotretinoin is prescribed by
medical professionals with hopes of eradicating most of the acne
production and to decrease the inflammation of future breakouts
(Layton, 2009).
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b. Topical
Systemic medications are known amongst the medical community
as the most effective for treating severe acne. However; topical acne
treatments are used more regularly than systemic ones and are usually
prescribed prior to or in combination with systemic treatments (Penna,
Ponti, Sparavigna, Tenconi, 2015). Topical acne treatments are
typically prescribed to patients who suffer from mild-to-moderate acne,
and it often take six to eight weeks to see a response (Freiman, Kraft,
2011). Topical treatments may also be prescribed to prevent the side
effects that sometimes occur during the use of systemic medications,
such as gastrointestinal issues (Adawiyah, Priya, Roshidah, 2010).
The most common side effects of topical acne treatments are skin
irritation or dryness where the treatment has been applied (Freiman,
Kraft, 2011). These may be soothed by including creams, face lotions,
or ointments that are made for remedying dry and irritated skin into the
patient’s skincare routine (Freiman, Kraft, 2011). Topical acne
treatments are also prescribed in various forms of retinoids and
antimicrobials (Freiman, Kraft, 2011).
Retinoids are a derivative of vitamin A that are used to bind with
nuclear receptors to regulate epithelial cell growth (skin cell growth)
and are prescribed in either a gel, liquid, or cream form (American
Osteopathic College of Dermatology). These medications encourages
follicular keratinocytes in order to inhibit comedone formation by

A RISK BENEFIT ANALYSIS OF TREATMENTS FOR CYSTIC ACNE

30

unblocking clogged pores (American Osteopathic College of
Dermatology & Freiman, Kraft, 2011). The topical retinoids that are
most frequently prescribed are adapalene, tretinoin, alitretinoin, and
tazarotene (American Osteopathic College of Dermatology). Those
being treated for cystic acne with a retinoid are requested to apply the
medication in small amounts once daily approximately thirty minutes
after washing their face (American Osteopathic College of
Dermatology). Topical retinoids may also be used to treat
hyperpigmentation such as acne scars as well as other skin conditions
such as psoriasis (American Osteopathic College of Dermatology). The
downfall of these medications is that while they can be used for
treatment of inflammation caused by acne and acne scars, they are
most commonly prescribed for patients with mild-to-moderate acne are
not as effective as other known treatments for cystic acne (American
Osteopathic College of Dermatology).
Patients dealing with cystic acne may also be prescribed a topical
antimicrobial to treat inflammation (Freiman, Kraft, 2011). The most
common topical antimicrobial prescribed is benzoyl peroxide. Benzoyl
peroxide assists in counteracting the antibiotic resistance of P. acnes
while possessing anti-inflammatory characteristics and being able
avert the formation of comedones (Freiman, Kraft, 2011). These
medications are prescribed in numerous strengths depending on the
patient’s experience and skin disorder. The strength reaches up to
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10.0% benzoyl peroxide concentration, which may be more irritating to
those who are not used to the effects of this treatment (Freiman, Kraft,
2011). It is strong enough that it is able to bleach any fabrics with
which it may come in contact, so this is a concern that some patients
have before using this medication (Freiman, Kraft, 2011). Benzoyl
peroxide kills P. acnes within the skin by emitting oxygen throughout
the affected hair follicles and sebaceous glands (Freiman, Kraft, 2011).
Other topical antimicrobials used include clindamycin and
erythromycin because they may be tolerated more easily while still
being able to decrease the number of inflamed acne lesions (Freiman,
Kraft, 2011). However; when used alone and not in conjunction with
benzoyl peroxide, these medications could increase the number of
antibiotic resistant P. acnes in less than a month of use (Freiman,
Kraft, 2011). Even though erythromycin and clindamycin have
antimicrobial characteristics, antibiotic resistant Staphylococcus aureus
and Staphylococcus epidermidis may form or increase in numbers in
and around the part of the body being treated with one of these topical
treatments (Freiman, Kraft, 2011).
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c. Light Therapy
Although systemic and topical acne treatments are the most
recommended for treating cystic acne, researchers have tested
different forms of light therapy for decreasing acne causing bacteria
and inflammation. This research did observe patients whose acne had
decreased inflammation after they experienced contact with natural
sunlight (Adya, Inamadar, Pei, Tsoukas, 2015). It was determined that
the porphyrins, which are produced naturally inside of the sebaceous
glands by the P. acnes bacteria, were capable of absorbing light
wavelengths between 400 to 700 nm (Adya, Inamadar, Pei, Tsoukas,
2015). This absorption of light promotes photo-excitation of the
porphyrins, which leads to the release of oxygen and free radicals that
can cause bacterial suicide within the P. acnes (Adya, Inamadar, Pei,
Tsoukas, 2015). Researchers have deduced that red lights, which
have a longer wavelength, are capable of reaching deeper into the skin
towards the sebaceous glands to focus on utilizing cytokine from
macrophages to produce anti-inflammatory properties (Adya,
Inamadar, Pei, Tsoukas, 2015). Blue lights are also able to decrease
inflammation caused by acne, however; they are more effective when
used in combination with red light (Adya, Inamadar, Pei, Tsoukas,
2015). In order to determine the efficacy of light therapy, studies were
done to compare subjects being treated with blue light or blue-red light
therapy to those being treated with either a systemic or topical
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treatment (Adya, Inamadar, Pei, Tsoukas, 2015). Studies were also
done to test whether or not using light therapy in unison with other well
known acne treatments would be beneficial for reducing acne
inflammation (Adya, Inamadar, Pei, Tsoukas, 2015). After many
experiments were done to compare blue and blue-red light therapy to
other types of cystic acne treatment, it was determined that the light
therapy was best used for treating mild-to-moderate cases of acne due
to the severe inflammation that is caused by cystic acne lesions (Adya,
Inamadar, Pei, Tsoukas, 2015). It was also determined that by
incorporating light therapy along with, not in place of, systemic or
topical acne treatments, a decrease in the number of lesions and
severity of the inflammation could occur (Adya, Inamadar, Pei,
Tsoukas, 2015). The light therapy was also credited with decreasing
the sebaceous gland size and for cutting down sebum production
(Adya, Inamadar, Pei, Tsoukas, 2015). However; if the distribution of
the treatment is misused, there may be photothermal harm to the
sebaceous glands as well as phototoxic damage to the skin due to
improper exposure of light (Adya, Inamadar, Pei, Tsoukas, 2015).
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SURVEY OF MEDICAL PROFESSIONALS
a. Objective
The objective of the research conducted for this thesis was to
evaluate the risks and benefits of the different methods of treatment for
patients with cystic acne as well as to determine what treatment is
most frequently prescribed to them. A simplified survey of medical
professionals such as dermatologists, family medicine doctors, and
dermatology physician assistants was performed in order to answers
questions like, "Which type of treatment and what treatment method is
used on a regular basis when treating cystic acne?" and, "Who treats
patients with cystic acne and what do they use?”
b. Methods
The methodology of the interview process with the medical
professionals was as follows: the medical professionals were selected
from local Shelby medical practices as well as from medical practices
in the Lake Norman-Charlotte area. In order to obtain enough data to
evaluate, the initial number of intended interviewees was six to eight
medical professionals. The professionals were contacted individually
and asked if they would like to participate in answering a short survey
about their experience with treating acne, specifically cystic acne. They
were required to provide verbal consent in order to participate. If they
declined, it was politely accepted and the researcher continued on to
the next person. If they accepted, they were asked to provide verbal
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consent to record the phone call and their answers for the survey
questions through voice recording and typed notes. The phone calls
were recorded in order to accurately remember their answers. A script
was used to ask them for their verbal consent in order to offer
reassurance to the professionals that their privacy would be protected
and patient information would not be a topic of conversation in order to
abide by HIPAA. HIPAA stands for the Health Insurance Portability and
Accountability Act (Rouse, 2019). See appendix A to read the verbal
consent script. Once verbal consent was acquired, they were asked to
answer nine brief questions. See page appendix B to read the blank
copy of the survey. If the professionals answered no to questions three
or five, the survey ended because they did not have personal
experience or treatment methods for cystic acne and their data would
not apply to this research. The number of professionals who have
treated cystic acne was recorded in a table along with their suggested
treatments to determine if there is a link between the treatments. The
reason for their recommendations on certain treatments was used to
further answer the research questions. The medical professionals will
be informed of this during the request for consent. The surveyed
professionals are referred to as: subject 1, a dermatologist; subject 2, a
dermatology PA; or subject 3, a family medicine doctor and so forth
throughout the written and presentation portions of this thesis. Those
who answered the survey were not informed of anyone else who was
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interviewed or the other survey answers so that their responses were
unbiased. The individual answers of the medical professionals are
provided in appendix C.
c. Responses
Three medical professionals responded to the survey request and
allowed their answers the answers to be recorded. It was noted that
three was not the preferred number of participants for this survey,
however; the three medical professionals that responded had some
diversity amongst their professions.
The first response was from a dermatologist who has been
practicing medicine since 1997. He underwent a three-year
dermatology residency and after medical school he became board
certified. The majority of the dermatologist’s patients that have acne
are teenagers, however; the dermatologist has also treated patients
with acne up to eighty years old. A dermatologist’s job largely consists
of treating patients with acne. Although other medical professionals are
equipped to treat this skin disorder as well, patients with cystic acne
are commonly referred to a dermatologist. Based on the
dermatologist’s experience with treating cystic acne, they recommend
systemic and topical acne medications that consist of isotretinoin. As
previously mentioned, Accutane is the name brand of isotretinoin. The
benefits of Accutane that have been observed by the dermatologist are
that this medication is the closest researchers have been to finding a
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cure for cystic acne and that 95% of patients who complete their
suggested Accutane prescription do not have future breakouts. In
order for a medical professional to prescribe Accutane or for a patient
to be prescribed this medication, both must have an account with
iPledge. iPledge is a program that was created in order to provide
necessary information about Accutane such as the potential risks for
both male and female patients as well as the potential concerns for
depression (iPledge). The only consequences that this dermatologist
considered for this medication are the political issues that have
occurred due to the creation of iPledge and the stigmas that have been
made about the medication potentially causing depression.
The second response to this survey was a physician assistant who
has been practicing dermatology since 2009. She went through a sixmonth dermatology training program once she completed physician
assistant school, and she does treat patients for acne in general as
well as cystic acne. The average age range of patients that she treats
for cystic acne is between thirteen to eighteen years old. When treating
a patient that is troubled by cystic acne, the dermatology PA most
frequently prescribes isotretinoin because she also believes that this
medication can lead to complete clearance of acne. The dermatology
PA concluded that the consequences of this treatment include dryness,
teratogenicity, mood changes, blood work, and frequent dermatology
appointments. She also mentioned that a patient taking Accutane may
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have difficulty driving at night and muscle aches, which are two side
effects that haven’t been discussed in the research collected for this
thesis.
The third and last response received for this survey was from a
doctor that has been practicing family medicine since 2008.She does
treat patients with acne, however; she did not undergo extra training to
do so except for the general training they received in medical school
and a four-week rotation in dermatology. The family medicine doctor
does begin treatment for cystic acne and she commonly treat patients
between the ages of twelve to fifty years old for this type of acne. The
topical treatments that she frequently prescribes to treat cystic acne
include Retin A, benzoyl peroxide, topical clindamycin, and adapalene.
If these topical treatments are not effective, the doctor will refer the
patient to a dermatologist so that the patient may be treated with
Accutane. The doctor claimed that the benefit of topical treatments was
that the patient will experience less systemic side effects, but the
benefit of oral antibiotics is that they are more effective at treating deep
cystic acne. The doctor also claimed that the benefit of Accutane is
that it is more capable of eradicating cystic acne and preventing future
lesions. She stated that consequence of topical treatments is that they
do not entirely resolve the issues with deep cystic acne and that the
consequence or oral antibiotics is that using this treatment may result
in bacteria that are antibiotic resistant. She also noted that the
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consequences of Accutane are the patient’s mucous membranes may
become dry and that there are issues with teratogenicity in female
patients if they become pregnant while on the medication.
d. Conclusion of data
The number of responses for this survey was not preferable for
determining a universal treatment for cystic acne. However; there was
some variation within medical backgrounds amongst the three
professionals that responded. Therefore, the surveys did conclude that
three different medical professionals with different levels of
experiences all recommended Accutane as the most effective course
of treatment for reducing and potentially eradicating cystic acne. Based
on the survey responses, it was determined that the medical
professionals believed that the outcome of this treatment outweighed
the consequences.
All of the professionals provided a verbal or written agreement to
answer the survey and also allowed their answers to be recorded for
research purposes. Out of the professionals surveyed, none of them
answered no to questions number three or five so therefore all three
surveys were permitted for use. The surveys provided were edited to
provide a clear understanding of the answers, but the integrity of the
answers was not disrupted. Overall, those that answered the survey
were pleased to be able to provide useful information on this topic and
to demonstrate their knowledge on acne treatments.
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CONCLUSION
Acne, specifically cystic acne, is difficult to treat without the guidance of a

trained medical professional so it is helpful to know the options for treatments
as well as the benefits and consequences of those treatments. The current
treatments that are frequently used for decreasing cystic acne lesions are
systemic, topical, and light therapy. As previously mentioned, and based on
the research collected through online databases and the survey of medical
professionals, systemic Accutane is the best course of treatment for severe,
stubborn cystic acne over other acne treatments. This is the best course of
treatment because it is the only known medication to this date that provides
complete or almost complete clearance in patients with cystic acne. Also,
despite the concerns that coincide with systemic medications and the
potential side effects of Accutane, this medication received notable praise
from the medical professionals that completed the survey used for this
research. It was also determined through research that Accutane may not be
the best course of treatment for every patient, so it is wise to seek medical
advice on an initial medication prior to Accutane. By testing out other
systemic or topical medications first, it will determine whether or not Accutane
is necessary for that specific patient or not. As researchers and medical
professionals continue to observe the effects of other medications, a new
medication may later be determined as a more universal course of treatment
for severe cystic acne, but for the time being, Accutane is the most effective
when aiming to cure a patient’s cystic acne.
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XII. APPENDIX
APPENDIX A: VERBAL CONSENT SCRIPT
“Good morning/afternoon Dr./Mr./Mrs. So-and-so. My name is Callie Elliott and I
am a senior biology major at Gardner-Webb University. I am currently conducting
research for my Honors thesis on treatments for cystic acne and I was wondering
if you would do me the honor of participating in a short survey regarding how you
treat this form of acne. The answers will be used to answer my thesis question as
to who treats cystic acne, which type of treatment is used, and what treatments
are most commonly used amongst medical professionals to treat this skin
condition. Your name, medical practice, and graduate schools will not be
documented and none of my questions will require patient specific answers in
order to follow HIPAA regulations.”
IF NO: “I understand, thank you for your time and have a blessed day.”
IF YES: “Thank you for your consent Dr./Mr./Mrs. So-and-so. May I also have
your consent to document your answers to the survey in a word document as
well as to record this phone call so that I may reference the answers within my
thesis?”
IF NO: “I understand, in order to use your answers as a part of my research I will
need to document them so that I may recall your methods of treatment when
writing my thesis. If that is an issue, I will respect your privacy and I will not be
able to conduct my survey with you today. Thank you for your time and have a
blessed day.”
IF YES: “Thank you again, I will now proceed with the survey”
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APPENDIX B: BLANK SURVEY

1. How long have you been practicing medicine?

2. What is your medical specialty?

3. Do you treat patients with acne?

4. Did you receive extra training to treat patients with acne?

5. Do you treat patients with cystic/severe acne?

6. What age range do you treat most often for cystic acne?

7. What treatment method do you recommend most often for cystic acne
(severe)?

8. What are the benefits of that treatment?

9. What are the consequences of that treatment?
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APPENDIX C: SURVEY RESPONSES
Answers from the Dermatologist:
1. How long have you been practicing medicine?
He has been practicing medicine since 1997.
2. What is your medical specialty?
Their specialty is Dermatology.
3. Do you treat patients with acne?
Yes, he does treat patients with acne.
4. Did you receive extra training to treat patients with acne?
Yes, he went through three years of a dermatology residency with board
certification.
5. Do you treat patients with cystic/severe acne?
Yes, he does treat patients with cystic/severe acne.
6. What age range do you treat most often for cystic acne?
He treats teenagers most frequently for cystic acne, but they may also
treat patients up to eighty years old.
7. What treatment method do you recommend most often for cystic acne
(severe)?
He recommends systemic, oral antibiotics or topical, isotretinoin
8. What are the benefits of that treatment?
He believes that the benefit of Accutane is that it is the closest to a cure
for cystic acne. 95% of patients do not have reoccurrence after following
the recommended usage.
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9. What are the consequences of that treatment?
He believes that there are no consequences other than the political issues
that have occurred due to iPledge and the concerns over Accutane being
a teratogenic drug because of societal concerns that have become more
prevalent.
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Answers from a Dermatology Physician Assistant:
1. How long have you been practicing medicine?
She has been practicing medicine since 2009
2. What is your specialty?
Her specialty is Dermatology
3. Do you treat patients with acne?
Yes, she does treat patients with acne.
4. Did you receive extra training to treat patients with acne?
Yes. She did a 6-month Dermatology training program after Physician
Assistant School.
5. Do you treat patients with cystic/severe acne?
Yes, she does treat patients with cystic/severe acne.
6. What age range do you treat most often for cystic acne?
She treats patients in the age range 13-18 years old most frequently for
cystic acne.
7. What treatment method do you recommend most often for cystic acne
(severe)?
She recommends isotretinoin for treatment of severe acne.
8. What are the benefits of that treatment?
She believes that the benefit of Accutane is that this treatment usually
allows for complete clearance of acne.
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9. What are the consequences of that treatment?
She concluded that there can be side effects for Accutane which include,
but are not limited to, dryness, difficulty driving at night, teratogenicity,
muscle aches, mood changes, frequent appointments, and blood work.
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Answers from the Family Medicine Doctor:
1. How long have you been practicing medicine?
She has been practicing since 2008.
2. What is your medical specialty?
She practices Family Medicine
3. Do you treat patients with acne?
Yes, she treats patients with acne
4. Did you receive extra training to treat patients with acne?
No, she went through the general training through medical school and
residency training, which included a 4-week rotation in Dermatology.
5. Do you treat patients with cystic/severe acne?
Yes, she does start treatment for cystic acne, but often refer patients to a
dermatologist if it is severe or not responding to their treatments.
6. What age range do you treat most often for cystic acne?
She treats patients 12-50 years old for cystic acne
7. What treatment method do you recommend most often for cystic acne
(severe)?
She recommends topical treatments such at Retin A, benzoyl peroxide,
topical clindamycin, and adapalene to start out if the patient is not
responding to minocycline or doxycycline. If all these fail, they usually will
refer the patient to dermatology to look into Accutane.
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8. What are the benefits of that treatment?
The doctor stated that the benefit of using topical treatments only is the
patient will experience less systemic side effects. The benefit of oral
antibiotics is that they can more effective at eradicating deep cystic acne.
The benefit of Accutane is that it is very effective at eradicating cystic acne
and many times it does not return.
9. What are the consequences of that treatment?
The consequence of topical treatments only is that many times they do not
completely resolve the deep cystic acne problem. The consequence of
oral antibiotics is that bacteria can become resistant to the antibiotics and
they no longer work. The consequence of Accutane is side effects of
teratogenicity and drying of the mucous membranes
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APPENDIX D: IRB APPLICATION
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